QV Bioelectronics

QV Bioelectronics develops GRACE, an implantable device platform designed to treat solid tumours, specifically targeting glioblastoma in adults. The device is placed during surgery to deliver continuous, precisely targeted electric fields that disrupt cancer cell division while sparing healthy tissue. The technology aims to enhance brain tumour treatment by providing therapy directly from within the body immediately following surgical intervention.